EX-32.2 6 ex_113692.htm EXHIBIT 32.2 ex_113692.htm

Exhibit 32.2

 

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Scott Kellen, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)

 

the Quarterly Report on Form 10-Q of Sun BioPharma, Inc. for the quarter ended March 31, 2018 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

     

(2)

 

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Sun BioPharma, Inc.

 

Dated: May 14, 2018

 

 

 

/s/ Susan Horvath

 

Susan Horvath

 

Chief Financial Officer

 

(Principal Financial Officer and Principal

 

Accounting Officer)